BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $336,000 | -37.8% | 20,645 | -39.6% | 0.02% | -51.9% |
Q2 2021 | $540,000 | +382.1% | 34,159 | +44.9% | 0.05% | +300.0% |
Q2 2020 | $112,000 | -58.4% | 23,568 | -69.7% | 0.01% | -50.0% |
Q4 2019 | $269,000 | +460.4% | 77,838 | +361.7% | 0.03% | +550.0% |
Q3 2019 | $48,000 | -11.1% | 16,860 | +48.2% | 0.00% | +33.3% |
Q1 2018 | $54,000 | – | 11,374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |